CDSCO Places Four CNS Drugs Under Schedule H1 Controls Over Abuse Concerns

The Central Drugs Standard Control Organization (CDSCO) has placed four widely used Central Nervous System (CNS) medications under stringent Schedule H1 controls in Hyderabad and across the country. The regulatory move aims to curb casual over-the-counter availability and rising trends of off-label intoxication for recreational purposes.

The four drugs brought under the tightened regulations are Zopiclone, Gabapentin, Flupentixol, and Carisoprodol. Through an official notification, the drug regulator has mandated physical prescription tracking, strict record-keeping protocols, and special warning labels on packaging for all four substances.

The intervention follows specific concerns flagged by the Drugs Consultative Committee regarding the widespread abuse of these medications. Authorities noted that easy over-the-counter access was enabling individuals dealing with substance addiction to misuse the formulations for intoxication.

Under the new Schedule H1 rules, these medications can now be dispensed strictly upon the presentation of a valid medical prescription. Chemists and pharmacies are required to maintain detailed audit registers documenting every sale, including the patient's name, residential address, and the complete details of the prescribing doctor.

The regulated drugs serve various medical purposes. Zopiclone is a hypnotic medication widely prescribed for the short-term management of insomnia, while Gabapentin is used to manage seizure control and treat neuropathic pain. Flupentixol serves as an antipsychotic drug prescribed for anxiety and depressive symptoms. Carisoprodol is a muscle relaxant known to metabolise in ways that trigger high psychological dependence and euphoria-seeking misuse among consumers.

In addition to sales registers, the CDSCO has mandated packaging updates. Manufacturers must include special packaging featuring a prominent red-bordered warning box alongside the symbolic red "Rx" sign to warn buyers against self-medication.